932 filings
Page 7 of 47
6-K
ATHE
Alterity Therapeutics Ltd
21 Sep 22
Report of Foreign Private Issuer
6:02am
6-K
ATHE
Alterity Therapeutics Ltd
20 Sep 22
Alterity Therapeutics Receives U.S. FDA Approval for Investigational New Drug
6:02am
6-K
ATHE
Alterity Therapeutics Ltd
31 Aug 22
Report of Foreign Private Issuer
8:39pm
6-K
ATHE
Alterity Therapeutics Ltd
31 Aug 22
Report of Foreign Private Issuer
2:08pm
20-F
2022 FY
ATHE
Alterity Therapeutics Ltd
Annual report (foreign)
31 Aug 22
12:24pm
6-K
ATHE
Alterity Therapeutics Ltd
31 Aug 22
Report of Foreign Private Issuer
11:54am
SC 13D/A
ATHE
Alterity Therapeutics Ltd
26 Aug 22
ALTERITY THERAPEUTICS / Life Biosciences ownership change
5:16pm
6-K
ATHE
Alterity Therapeutics Ltd
25 Aug 22
Alterity Therapeutics Launches ATH434 Phase 2 Clinical Trial for the Treatment of Patients with Multiple System Atrophy in Europe
6:16am
6-K
ATHE
Alterity Therapeutics Ltd
24 Aug 22
Alterity Therapeutics granted extension by Nasdaq to regain compliance minimum bid price requirement
6:03am
SC 13D/A
Life Biosciences LLC
1 Aug 22
ALTERITY THERAPEUTICS / Life Biosciences ownership change
5:21pm
6-K
ATHE
Alterity Therapeutics Ltd
22 Jul 22
Appendix 4C – Q4 FY22 Quarterly Cash Flow Report
6:02am
SC 13D/A
ATHE
Alterity Therapeutics Ltd
21 Jul 22
ALTERITY THERAPEUTICS / Life Biosciences ownership change
12:00am
6-K
ATHE
Alterity Therapeutics Ltd
5 Jul 22
Report of Foreign Private Issuer
9:37pm
6-K
ATHE
Alterity Therapeutics Ltd
30 Jun 22
Alterity receives a $4.1 million R&D Tax Incentive Refund
6:36am
6-K
ATHE
Alterity Therapeutics Ltd
27 Jun 22
Report of Foreign Private Issuer
6:05am
6-K
ATHE
Alterity Therapeutics Ltd
23 Jun 22
Alterity Therapeutics Announces Regulatory Authorization to Proceed with ATH434 Phase 2 Clinical Trial in Italy
6:02am
6-K
ATHE
Alterity Therapeutics Ltd
21 Jun 22
Alterity Therapeutics to Present at the at VirtualInvestorConferences.com Life Sciences Investor Forum
8:05am
6-K
ATHE
Alterity Therapeutics Ltd
14 Jun 22
Alterity Therapeutics to Present at the GCFF Virtual Conference 2022 – Investing in Healthcare
6:02am
6-K/A
ATHE
Alterity Therapeutics Ltd
3 Jun 22
Alterity Therapeutics Launches ATH434 Phase 2 Clinical Trial for the Treatment of Patients with Multiple System Atrophy
6:05am
6-K
ATHE
Alterity Therapeutics Ltd
1 Jun 22
Alterity Therapeutics Launches ATH434 Phase 2 Clinical Trial for the Treatment of Patients with Multiple System Atrophy
9:28pm